Effects of tetrahydroxystilbene glucoside on mouse liver cytochrome P450 enzyme expressions

References

• Angulo P. (2002). Nonalcoholic fatty liver disease. N Engl J Med 346:1221–31
   PubMed Web of Science ®Google Scholar
• Bao B, Geng T, Cao Y, et al. (2012). Effects of schizonepetin on activity and mRNA expression of cytochrome P450 enzymes in rats. Int J Mol Sci 13:17006–18
   PubMed Web of Science ®Google Scholar
• Barbier O, Fontaine C, Fruchart JC, Staels B. (2004). Genomic and non-genomic interactions of PPARα with xenobioticmetabolizing enzymes. Trends Endocrinol Metab 15:324–30
   PubMed Web of Science ®Google Scholar
• Blomme EA, Yang Y, Waring JF. (2009). Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. Toxicol Lett 186:22–31
   PubMed Web of Science ®Google Scholar
• Bolt M, Koos PH, Their R. (2003). The cytochrome P450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 76:174–85
   PubMed Web of Science ®Google Scholar
• Chang MJ, Xiao JH, Wang Y, et al. (2012). 2, 3, 5, 4′-Tetrahydroxystilbene-2-O-beta- D-glucoside improves gastrointestinal motility disorders in STZ-induced diabetic mice. PLoS One 7:e50291
   Google Scholar
• Denison MS, Nagy SR. (2003). Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43:309–34
   PubMed Web of Science ®Google Scholar
• Dixon J, Lane K, MacPhee I, Philips, B. (2014). Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism. Int J Mol Sci 15:2538–53
   PubMed Web of Science ®Google Scholar
• Gao N, Qi B, Liu FJ, et al. (2014). Inhibition of baicalin on metabolism of phenacetin, a probe of CYP1A2, in human liver microsomes and in rats. PLoS One 9:e89752
   Google Scholar
• Guengerich FP, Shimada T. (1998). Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res 400:201–13
   PubMed Web of Science ®Google Scholar
• Huang Y, Zheng SL, Zhu HY, et al. (2014). Effects of aescin on cytochrome P450 enzymes in rats. J Ethnopharmacol 151:583–90
   PubMed Web of Science ®Google Scholar
• Klein K, Zanger UM. (2013). Pharmacogenomics of cytochrome P450 3A4: recent progress toward the “missing heritability” problem. Front Genet 4:12–26
   PubMedGoogle Scholar
• Lu Y, Cederbaum AI. (2006). Enhancement by pyrazole of lipopolysaccharide- induced liver injury in mice: role of cytochrome P450 2E1 and 2A5. Hepatology 44:263–74
   PubMed Web of Science ®Google Scholar
• Lu Y, Cederbaum AI. (2008). CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 44:723–38
   PubMed Web of Science ®Google Scholar
• Lu Y, Cederbaum AI. (2010). CYP2E1 potentiation of LPS and TNFa-induced hepatotoxicity by mechanisms involving enhanced oxidative and nitrosative stress, activation of MAP kinases, and mitochondrial dysfunction. Genes Nutr 5:149–67
   PubMed Web of Science ®Google Scholar
• Nebert DW, Dalton TP. (2006). The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 6:947–60
   PubMed Web of Science ®Google Scholar
• Pan YZ, Gao W, Yu AM. (2009). MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37:2112–17
   PubMed Web of Science ®Google Scholar
• Rakhshandehroo M, Knoch B, Müller M, Kersten S. (2010). Peroxisome proliferator-activated receptor alpha target genes. PPAR Res 2010:612089
   PubMed Web of Science ®Google Scholar
• Rendic S. (2002). Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 34:83–448
   PubMed Web of Science ®Google Scholar
• Sinz M, Kim S, Zhu Z, et al. (2006). Evaluation of 170 xenobiotics as transactivators of human pregnane x receptor (hpxr) and correlation to known cyp3a4 drug interactions. Curr Drug Metab 7:375–88
   PubMed Web of Science ®Google Scholar
• Staudinger JL, Xu C, Biswas A, Mani S. (2011). Post-translational modification of pregnane x receptor. Pharmacol Res 64:4–10
   PubMed Web of Science ®Google Scholar
• Synold TW, Dussault I, Forman BM. (2001). The orphan nuclear receptor sxr coordinately regulates drug metabolism and efflux. Nat Med 7:584–90
   PubMed Web of Science ®Google Scholar
• Ueng YF, Jan WC, Lin LC, et al. (2002). The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Drug Metab Dispos 30:349–53
   PubMed Web of Science ®Google Scholar
• Venkateswarlu K, Lamb DC, Kelly DE, et al. (1998). The N-terminal membrane domain of yeast NADPH-cytochrome P450 (CYP) oxidoreductase is not required for catalytic activity in sterol biosynthesis or in reconstitution of CYP activity. J Biol Chem 273:4492–6
   PubMedGoogle Scholar
• Wang QL, Wu Q, Tao YY, et al. (2011). Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells. Hepatobiliary Pancreat Dis Int 10:502–8
   PubMed Web of Science ®Google Scholar
• Wang T, Gu J, Wu PF, et al. (2009). Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation. Free Radic Biol Med 47:229–40
   PubMed Web of Science ®Google Scholar
• Wang Z, Gorski JC, Hamman MA, et al. (2001). The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 70:317–26
   PubMed Web of Science ®Google Scholar
• Xu RA, Xu ZS, Ge RS. (2014). Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats. J Ethnopharmacol 151:1141–6
   PubMed Web of Science ®Google Scholar
• Yang Y, Wong SE, Lightstone FC. (2014). Understanding a substrate’s product regioselectivity in a family of enzymes: a case study of acetaminophen binding in cytochrome P450s. PLoS One 9:e87058
   Google Scholar
• Yao W, Fan W, Huang C, et al. (2013). Proteomic analysis for anti-atherosclerotic effect of tetrahydroxystilbene glucoside in rats. Biomed Pharmacother 67:140–5
   PubMedGoogle Scholar
• Zanger UM, Turpeinen M, Klein K, Schwab M. (2008). Functional pharmacogenetics/genomicsof humancytochromesP450involved in drugbiotransformation. Anal Bioanal Chem 392:1093–108
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu S, Zhang R, et al. (2013). Tetrahydroxystilbene glucoside antagonizes age-related α-synuclein overexpression in the hippocampus of APP transgenic mouse model of Alzheimer's disease. Restor Neurol Neurosci 31:41–52
   PubMedGoogle Scholar
• Zhou L, Hou Y, Yang Q, et al. (2012). Tetrahydroxystilbene glucoside improves the learning and memory of amyloid-β(1-42)-injected rats and may be connected to synaptic changes in the hippocampus. Can J Physiol Pharmacol 90:1446–55
   PubMed Web of Science ®Google Scholar
• Zhou SF, Koh HL, Gao YH, et al. (2004). Herbal bioactivation: the good, the bad and the ugly. Life Sci 74:935–68
   PubMed Web of Science ®Google Scholar
• Zhou SF, Yang LP, Zhou ZW, et al. (2009). Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2. AAPS J 11:481–94
   PubMed Web of Science ®Google Scholar